Qualcomm, Novartis Team Up For Remotely Monitored COPD Inhaler
This article was originally published in The Gray Sheet
Executive Summary
In its continued bid to expand the reach of its 2net connected health system, Qualcomm is working with Novartis to develop a new inhaler for patients with chronic obstructive pulmonary disease that can be used to remotely monitor treatment effectiveness.